semaglutide coming off market Is There A Shortage? Ozempic and Wegovy Availability Updates Affordable Semaglutide Is Coming: Should

Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist that effectively controls blood glucose and promotes weight loss, but discontinuation often leads to weight regain and glycemic deterioration

The most common side effects are gastrointestinal (nausea, vomiting, diarrhoea, constipation), not fever

Clinical trials have recorded improvements in lipids, including lower levels of triglycerides and "bad" LDL cholesterol, as well as increases in "good" HDL cholesterol

Some administrators request an LMN for weight-management prescriptions specifically

What This Looks Like in Practice If you're on Ozempic, Wegovy, or any GLP-1 medication, here's what an effective training approach includes: Frequency: 23 strength sessions per week minimum Focus: Compound movements squats, deadlifts, pressing, pulling that recruit the most muscle Protein: Aim for 1.62.2g per kg of bodyweight daily to offset appetite suppression Intensity: Keep training challenging appetite suppression can reduce perceived effort, but the muscle stimulus still needs to be there Recovery: Prioritise sleep and manage stress, both of which affect muscle retention Training on GLP-1 in Singapore: What to Expect Lower appetite can affect energy levels, especially in the first 48 weeks of GLP-1 use